Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients

Withdrawn before enrolling

Conditions studied: Depression, Anxiety

In brief

This is an observational study evaluating the safety and efficacy of dronabinol for the treatment of anxiety and/or depression in older adults. Participants who are prescribed dronabinol as part of a voluntary inpatient stay in McLean's Division of Geriatric Psychiatry will be interviewed about their mood and cognition on a weekly basis while on dronabinol.

Key facts

Study ID

NCT03369639

Run by

Mclean Hospital

People needed

0

Starts

2017-11-28

Expected to finish

2018-10-01

Last updated by the study team

2019-07-31

Who can join

Age: 50 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 50-89 years old (inclusive)
• Inpatient on the Older Adult Unit in South Belknap 1 at McLean Hospital
• Initiating dronabinol therapy for the treatment of any Diagnostic and Statistical Manual (DSM) 5 Major Depression or Anxiety Disorder Diagnosis
• Ability to provide informed consent
• Must be fluent in English

You may not qualify if…

• Delirium as determined by the Confusion Assessment Method (CAM)
• Serious or unstable medical illness, including cardiovascular, hepatic, renal, respiratory, endocrine, neurologic or hematologic disease, which might confound assessment of safety outcomes
• Seizure disorder
• Diagnosis of bipolar depression, Major depression with psychotic features, schizophrenia, schizoaffective disorder, dementia
• Use of dronabinol or marijuana in the last year
• Prescription of lithium or anticonvulsant medications (except gabapentin)
• Patient currently admitted involuntarily to McLean Hospital

Where it is running

• McLean Hospital — Belmont, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.